SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the U.S. Department of Commerce utilizes it for on-chain economic data verification and distribution, sparking excitement about real-world asset (RWA) integration. The community is discussing its potential to disrupt the finance industry and outperform competitors, drawing comparisons to Chainlink and CRO. Some traders are noting technical indicators that suggest potential for further gains.

Brewski

$BREWSKI.X is trending as users celebrate 'American spirit' and brotherhood, frequently pairing it with meme-related coins. The community is highlighting potential whale activity and positioning it as the 'next great American runner'. Conversations also suggest a potential connection to current political trends.

Aventus

Aventus ($AVT.X) is trending amid community excitement, with many highlighting its low market cap and potential for significant gains, especially as it's listed on Coinbase. Discussions revolve around breaking resistance levels and the possibility of a new exchange listing acting as a catalyst. Some users also point to its underlying technology and partnerships as reasons for its potential.

Ankr is a Web3 decentralized infrastructure provider that helps developers, dapps, and stakers easily interact with multiple blockchains. It allows you to create DApps using API and RPC, staking on Ankr Earn, and use customized blockchain solutions for businesses.

Ankr Network

Ankr Network ($ANKR.X) is trending amid mixed sentiment, with some community members highlighting its infrastructure role and potential for developers, while others express frustration with its price performance and call it a "scam token." Discussions also revolve around the upcoming Neura L1 blockchain and its potential impact on the token's utility and value, with some hoping for a coin burn mechanism to drive demand.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending due to concerns about production timelines for their Gravity SUV and the overall company's profitability, reflected in negative sentiment from some investors. Despite a recent commercial spot during an NFL game and news of accelerated Gravity SUV production, some community members express skepticism about Lucid's financial future and the effectiveness of the reverse stock split. Discussions also involve potential future funding from Saudi PIF and comparisons to other EV manufacturers like Tesla and Rivian.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor ($NVTS) is trending amid community discussions around a potential breakout and anticipation for news related to its partnership with Nvidia ($NVDA). Some traders speculate about a possible acquisition, while others are focused on insider trading activity and the impact of the new CEO, Chris Allexandre, on the company's future direction in AI data centers.

Pump.fun

$PUMP.X is trending as traders discuss its potential, recent website updates, and community takeover of creator rewards, driving bullish sentiment. Conversations revolve around potential breakout points, with community members calling for it to reach penny status. The coin is associated with the meme coin launchpad Pump.fun on the Solana network.

Trump For President

TRUMP.X is trending as the crypto market reacts to speculation around Trump's political activities and potential influence on the coin's value. The community is actively discussing price predictions and potential pumps, while also debating the merits and risks associated with investing in meme coins linked to public figures. Broader market factors, including economic data and potential policy changes, are also being considered in relation to the token's future performance.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CRMD is trending due to recent financial guidance updates and the completed acquisition of Melinta Therapeutics, with the community actively discussing the potential impacts of the acquisition and future revenue projections. Some are concerned about potential executive stock sales, while others are optimistic about the company's growth and the potential for a short squeeze. Discussions also revolve around DefenCath's adoption rates and potential CMS policy changes.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont is trending as investors discuss its aggressive capital allocation strategy amid strong gold prices, including a massive buyback program and significant shareholder returns. Community members are weighing the impact of these factors, alongside potential cost-cutting measures and unusual options activity, on the company's future performance and stock price, with some highlighting its potential for further gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cohance Lifesciences has been in a downtrend, losing 16% in the last month. Its shares hit a 52-week low last week driven by a weak show in June quarter (Q1 FY26) earnings and has extended the selloff on Monday too.&nbsp;The stock traded below a key support at ₹930, SEBI-registered analyst&nbsp;<a href="https://stocktwits.com/RAAkhileshJat">Akhilesh Jat</a> highlighted.&nbsp;<a href="https://stocktwits.com/symbol/COHANCE.NSE">Cohance stock</a> fell after reporting a sharp drop in profitability for Q1 FY26. The adjusted net profit was down 24.8% year-on-year (YoY) at ₹62.9 crore vs ₹83.5 crore.What Is The Retail Mood?Cohance was trending on top of the ‘Most Bearish’ list on Stocktwits at the time of writing.&nbsp;Data also shows that retail sentiment turned ‘extremely bearish’ amid ‘extremely high’ message volumes last week following its dismal results.&nbsp;<figure class="image"><img style="aspect-ratio:805/110;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_18_130030_png_3ef782fb0f.webp" alt="Screenshot 2025-08-18 130030.png" width="805" height="110"><figcaption>Cohance sentiment and message volume on Aug 18 as of 1:00 pm IST. | source: Stocktwits</figcaption></figure>Technical Breakdown&nbsp;He identified a breakdown from a Descending Triangle pattern, signalling further bearish momentum. Jat noted immediate support at ₹888, with resistance seen near ₹930–₹950 zone.With the breakdown below crucial support and weak earnings, the short-term bias remains negative unless the stock reclaims ₹930 on a closing basis, according to him.<stembedurl>https://stocktwits.com/RAAkhileshJat/message/625149817</stembedurl>Fundamental WatchCohance Lifesciences, a subsidiary of Suven Pharmaceuticals develops and manufactures New Chemical Entity (NCE) intermediates, APIs, speciality chemicals, and formulated drugs.&nbsp;On the fundamental front, Jat observed that Cohance was trading at a price to earnings (P/E) ratio of 134.43 against a sector P/E of 26.07. The company’s price-to-book ratio (P/B) stood at 21.22.He further added that it had a return on equity (ROE) of 14.64% and a return on capital employed (ROCE) of 19.24%.&nbsp;&nbsp;Reports suggest that all its promoter shares are pledged, which raises concerns over its outlook.&nbsp;Cohance shares have declined 21% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Generic pharmaceuticals laboratory, 9 April 2002. AFR Picture by ROBERT ROUGH (Photo by Fairfax Media via Getty Images via Getty Images)

Bearish Trend In Cohance: Stock Must Reclaim ₹930 To Avoid Deeper Selloff, Says SEBI Analyst

The pharma stock has fallen 16% in a month and now trades at a 52-week low. Retail sentiment has turned sharply bearish on Stocktwits.

Equity

The pharma stock has fallen 16% in a month and now trades at a 52-week low. Retail sentiment has turned sharply bearish on Stocktwits.


Cohance Lifesciences Ltd. manufactures chemical products. It specializes in providing pharmaceutical solutions to global life science companies. The firm engages in Contract Research & Manufacturing Services (CRMS) business where research and development is customized to the needs of global pharmaceutical customers. Its business segments include pharmaceutical solutions, active pharma ingredients, intermediates and formulations. The company was founded on November 6, 2018 and is headquartered in Hyderabad, Telangana.

Current Price	925.85
Prev Close	904.00
Open	906.00
Dividend Yield	0.00%
50-Day Moving Average	970.67
Beta	N/A
Avg. Volume	406,912.79
PE Ratio	98.02

52-Week High	1,360.00
52-Week Low	856.30
Market Capitalization	353.07B
EPS (Annual)	10.52
Price to Book	13.85
Revenue Per Employee	5.14M
Enterprise Value/EBITDA	N/A

COHANCE.NSE
Cohance Lifesciences Ltd

Feed

News

Sentiment

Fundamentals

Info

Latest COHANCE.NSE News

COHANCE.NSE Cohance Lifesciences Ltd